EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
    2.6.1.44 | alanine-glyoxylate transaminase deficiency |
1496924 |
Alanine glyoxylate aminotransferase deficiency: biochemical and molecular genetic lessons from the study of a human disease. |
causal interaction
ongoing research
unassigned |
4
2
0 |
| 2.6.1.44 | alanine-glyoxylate transaminase deficiency |
1763934 |
[Hepatic and renal transplantation in the treatment of type I hyperoxaluria] |
causal interaction
unassigned |
4
0 |
| 2.6.1.44 | alanine-glyoxylate transaminase deficiency |
12352890 |
Renal allograft survival in patients with oxalosis. |
causal interaction
diagnostic usage
unassigned |
4
3
0 |
| 2.6.1.44 | alanine-glyoxylate transaminase deficiency |
16904473 |
Treatment of primary hyperoxaluria type 1 with sequential liver and kidney transplants from the same living donor. |
causal interaction
diagnostic usage
unassigned |
4
3
0 |
| 2.6.1.44 | alanine-glyoxylate transaminase deficiency |
27512303 |
Recurrent truncating mutations in alanine-glyoxylate aminotransferase gene in two South Indian families with primary hyperoxaluria type 1 causing later onset end-stage kidney disease. |
causal interaction
unassigned |
4
0 |
| 2.6.1.44 | Arthritis, Rheumatoid |
28357606 |
Genetic variations in the alanine-glyoxylate aminotransferase 2 (AGXT2) gene and dimethylarginines levels in rheumatoid arthritis. |
causal interaction
unassigned |
2
0 |
| 2.6.1.44 | Atherosclerosis |
25620171 |
Missense variants of the alanine: glyoxylate aminotransferase 2 gene correlated with carotid atherosclerosis in the Japanese population. |
causal interaction
therapeutic application
unassigned |
4
2
0 |
| 2.6.1.44 | Atherosclerosis |
34320345 |
Dysregulated oxalate metabolism is a driver and therapeutic target in atherosclerosis. |
ongoing research
therapeutic application
unassigned |
3
2
0 |
| 2.6.1.44 | Atrial Fibrillation |
26984639 |
Associations of functional alanine-glyoxylate aminotransferase 2 gene variants with atrial fibrillation and ischemic stroke. |
causal interaction
ongoing research
therapeutic application
unassigned |
3
2
1
0 |
| 2.6.1.44 | Carcinoma, Hepatocellular |
26294768 |
AGXT2L1 is down-regulated in heptocellular carcinoma and associated with abnormal lipogenesis. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
4
3
1 |
